Lansodin 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 6.02 (7 x 4: ৳ 168.56)
Strip Price: ৳ 24.08
Medicine Details
Category | Details |
---|---|
Generic | Lansoprazole |
Company | Acme laboratories ltd |
Also available as |
Indications
- Short term treatment of active duodenal ulcer
- Maintenance of healed duodenal ulcers
- Short term treatment of active benign gastric ulcers
- Short term treatment of active erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Pathological hypersecretory conditions including Zollinger-Ellison Syndrome
- H. pylori eradication to reduce the risk of duodenal ulcer recurrence
Pharmacology
Substituted benzimidazole, PPI, blocks the final step of acid secretion by inhibiting H+/K+ ATPase enzyme system in gastric parietal cell; inhibits both basal and stimulated acid
Dosage & Administration
- Benign gastric ulcer: 30 mg daily in the morning for 8 weeks
- Duodenal ulcer: 30 mg daily in the morning for 4 weeks; maintenance 15 mg
- NSAID-associated duodenal or gastric ulcer: 15-30 mg daily for 4 weeks, followed by a further 4 weeks if not fully healed
- Zollinger-Ellison syndrome (and other hypersecretory conditions): Initially 60 mg once daily adjusted according to response; daily doses of 120 mg or more is given in two divided doses
- Gastroesophageal reflux disease: 30 mg daily in the morning for 4 weeks, followed by a further 4 weeks if not fully healed; maintenance 15-30 mg daily
- Acid-related dyspepsia: 15-30 mg daily in the morning for 2-4 weeks
Interaction
Selective inhibitor of the cytochrome P-450 monooxygenase system; potential effect on hepatic clearance, uncertain impact on oral combined contraceptive pill; physiological changes similar to those caused by omeprazole
Contraindications
Known hypersensitivity to any component of the formulation
Side Effects
- Possible induction of carcinoid tumors by profound acid suppression; rise in serum gastrin levels
- Long term treatment with a proton pump inhibitor in patients with Helicobacter pylori infection may accelerate the development of atrophic gastritis
- Dose dependent diarrhea, headache
Pregnancy & Lactation
Avoided in pregnancy unless there are compelling reasons
Precautions & Warnings
Gastric malignancy should be ruled out; hepatic impairment; pregnancy and lactation
Use in Special Populations
- Neonates: Not recommended for use
- Children: The youngest person to have received Lansodin in clinical trials was 13 years old
- The Elderly: No problems encountered in clinical use; no increase in adverse drug reactions
Therapeutic Class
Proton Pump Inhibitor
Storage Conditions
Store at 25° C
Related Brands
- Ulan 30 mg (Capsule (Enteric Coated)) - union-pharmaceuticals-ltd
- Lansoprol 30 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Lap 30 mg (Capsule (Enteric Coated)) - ambee-pharmaceuticals-ltd
- Zoton 30 mg (Capsule (Enteric Coated)) - general-pharmaceuticals-ltd
- Protolan 30 mg (Capsule (Enteric Coated)) - beximco-pharmaceuticals-ltd